Skip to content
Latest News
Performance Shipping And The John Paul Getty Method Of Drilling For Oil

Key points: Performance Shipping might be selling assets at the top of the market The deep discount to the stock issue is a puzzle as well Trading here could be interesti

Tim Worstall
Tim Worstall
Cloudbreak Discovery, CDL, Where Has The Romance Gone?

Key points: Cloudbreak Discovery has been disappointing recently It's the quality of the projects being organised Some of the romance has gone out of the base idea at pl

Tim Worstall
Tim Worstall
Horizonte Minerals Shares, HZM, Up 1,818%, No, Down 10% – Explained

Key points: Horizonte is up 1,800% by the usual tickers This is really more like a 10% fall The explanation is a share consolidation Horizonte Miner

Tim Worstall
Tim Worstall
GMT Crypto Price Prediction: Will GMT Recover From the Chinese Ban?

Key points: The GMT crypto has sold off immensely from its all-time highs. The latest decline occurred after the banning of Chinese users.

Simon Mugo
Cineworld Shares Soared 18.7% on ‘Top Gun Maverick’ Debut – Is It a Buy?

Key points: Cineworld shares soared 18.7% after Top Gun Maverick’s debut on Friday. Investors cheered the movie’s excellent opening weekend perform

Simon Mugo
LUNA Crypto Price Prediction: Should You Buy the New LUNA Coin?

Key points: The LUNA crypto price has gotten off to a good start following its airdrop. Investors bought the new LUNA token despite its predecessor

Simon Mugo
Here’s Why Echo Energy (ECHO) Shares Surged 9.8% Today. Is It a Buy?

Key points: Echo Energy shares surged 9.76% on an upbeat Argentina operations update. The energy company increased its overall gas production at Ocea

Simon Mugo
Here’s Why Avacta Shares Are Rising Despite the Lack of News

Key points: Avacta shares are rising despite the lack of new releases from the firm. The shares are rallying due to the positive investor sentiment

Simon Mugo
Abingdon Health (ABDX) Shares Rallied on Deepverge Deal. What’s Next?

Key points: Abingdon Health shares surged 7% on the Deepverge LFT contract. The two firms will collaborate t develop lateral flow tests for Modern

Simon Mugo
Cornish Metals Shares, CUSN, Bubble 3% On Sleitat – Does It Actually Matter?

Key points: Cornish Metals has sold a 1% royalty in Sleitat Given that South Crofty is now funded this is not material In the long term it's the global tin price that ma

Tim Worstall
Tim Worstall
Oxford Metrics Shares, OMG, Leap 30% On Yotta Sale – Could It Go Further?

Key points: Oxford Metrics has sold Yotta to Causeway Cash receipts will be £52 million This allows the further development of Vicon, the core technology

Tim Worstall
Tim Worstall
Genedrive Shares, GDR, Up 9% On CTDA Approval – More To Come?

Key points: Genedrive has achieved a CDTA for its covid test This now allows sales - bulk and direct - in the UK What matters now is how many sales are actually generated

Tim Worstall
Tim Worstall
Here’s Why the 4D Pharma (DDDD) Shares Fell Despite Cancer Progress

Key points: 4d Pharma shares fell despite making progress in its cancer drugs. The biotech firm’s shares rose briefly before falling back down. Sour investor sentime

Simon Mugo
Jasmy Crypto Price Prediction: Will the IoT Token Ever Recover?

Key points: The Jasmy crypto price has fallen 86.2% YTD but is now trading sideways. The token could rally higher with the leading cryptos if the m

Simon Mugo
ProShares UltraShort ETF (SQQQ) Stock Price Is Falling. Is This the End?

Key points: The ProShares UltraPro Short QQQ ETF (SQQQ) stock price is falling. Does this mark the end of its recent rally? What should investors b

Simon Mugo
Cleveland Cliffs (CLF) Stock Fell 31% From Its April High. What’s Next?

Key points: Cleveland-Cliffs (CLF) stock has fallen 31% from its April high. However, the CLF stock looks like a buy at current prices.

Simon Mugo
The Xpeng (XPEV) Stock Price Has Fallen 56% YTD. Is the Firm a Buy?

Key points: The Xpeng stock price has fallen 56% in 2022. Should you buy it? The Chinese EV company has ambitious plans for the rest of 2022.

Simon Mugo
Iovance Biotherapuetics Stock Down 50% On Trial Data – Some You Lose

Key points: Iovance Biotherapeutics (NASDAQ: IOVA) stock is down 50% premarket It is suffering from trial data for its melanoma treatment The short interest in IOVA was so

Tim Worstall
Tim Worstall
Gap Stock, GPS, Drops 16% – The Fashion Brand That’s Out Of Fashion?

Key points: Gap announced results with a large EPS miss Guidance for full year revenues is also down Is Gap simply too out of fashion now?

Tim Worstall
Tim Worstall
Alien Metals (UFO) Shares Rallied on a Drilling Update. What’s Next?

Key points: Alien Metals shares edged higher after issuing its latest drilling update. The junior miner just started phase 4 RC drilling at its Han

Simon Mugo
Analysis Stocks Markets Strategies